T. Rowe Price
TROW Nasdaq Asset Management & Custody Banks Financials FY2016βFY2025
T. Rowe Price's revenue rose 3.1% to $7.3 billion in fiscal 2025. Its operating margin was 29.9%, down from 32.9% a year earlier. Free cash flow was $1.5 billion, up 17.2%. It paid out $1.8 billion in dividends and buybacks, 119% of free cash flow. The diluted share count fell 1.3%.
About these figures. T. Rowe Price has no debt; its balance sheet shows no borrowings.
What T. Rowe Price does
No business description yet.
- Legal name
- PRICE T ROWE GROUP INC
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-008002
0001113169
Revenue and margins
T. Rowe Price had $7.3B of revenue in fiscal 2025, up 3.1% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 7.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.5B in fiscal 2025, 20.2% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
T. Rowe Price returned $1.8B to shareholders in fiscal 2025, 119% of free cash flow. The diluted share count fell 1.3%.
Value T. Rowe Price yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $3.4B and divides by 220.3M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 10.5x Β· peers 30.7x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably T. Rowe Price can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.5B | $1.8B | $2.1B | $2.6B | $3.4B |
| Debt incl. finance leases | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Total assets | $12.5B | $11.6B | $12.3B | $13.5B | $14.3B |
| Total liabilities | $2.3B | $2.0B | $2.0B | $2.0B | $2.3B |
| Shareholders' equity | $9.0B | $8.8B | $9.5B | $10.3B | $10.9B |
| Net debt (β = net cash) | β$1.5B | β$1.8B | β$2.1B | β$2.6B | β$3.4B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$1.9M
3 insiders
Of sales under plans
0%
$0.0M
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | 4.8% | 3.2% | 2.4% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| T. Rowe Price TROW | $22.3B | 3.1% | 29.9% | 20.2% | 21.7% | 10.5x | β | |
| Invesco IVZ | $12.8B | 5.1% | β10.9% | 22.6% | β3.8% | β | β | Compare β |
| Franklin Resources BEN | $16.0B | 3.5% | 6.9% | 10.4% | 3.6% | 21.1x | β | Compare β |
| Brookfield Asset Management BAM | β | 21.0% | β | 43.4% | β | β | β | Compare β |
| Carlyle Group CG | $14.2B | β11.9% | β | β70.6% | 13.7% | 40.2x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $4.3B | $4.9B | $5.4B | $5.6B | $6.2B | $7.7B | $6.5B | $6.5B | $7.1B | $7.3B |
| Operating income | $1.7B | $2.1B | $2.4B | $2.4B | $2.7B | $3.7B | $2.4B | $2.0B | $2.3B | $2.2B |
| Pretax income | $2.0B | $2.5B | $2.4B | $2.9B | $3.2B | $4.0B | $1.9B | $2.5B | $2.8B | $2.9B |
| Income tax | $707M | $924M | $616M | $678M | $719M | $896M | $499M | $655M | $684M | $667M |
| Net income | $1.2B | $1.5B | $1.8B | $2.1B | $2.4B | $3.1B | $1.6B | $1.8B | $2.1B | $2.1B |
| Diluted EPS | $4.75 | $5.97 | $7.27 | $8.70 | $9.98 | $13.12 | $6.70 | $7.76 | $9.15 | $9.24 |
| Diluted shares | 0.25B | 0.25B | 0.25B | 0.24B | 0.23B | 0.23B | 0.23B | 0.22B | 0.22B | 0.22B |
| Cash flow | ||||||||||
| Cash from operations | $171M | $230M | $1.6B | $1.5B | $1.9B | $3.5B | $2.4B | $1.2B | $1.7B | $1.8B |
| Capital expenditure | $148M | $186M | $169M | $205M | $215M | $239M | $238M | $308M | $423M | $274M |
| Free cash flow | $22.2M | $43.4M | $1.5B | $1.3B | $1.7B | $3.2B | $2.1B | $911M | $1.3B | $1.5B |
| Depreciation and amortization | $133M | $144M | $160M | β | β | β | β | β | β | β |
| Stock-based compensation | $162M | $152M | $197M | $207M | $246M | $275M | $285M | $266M | $247M | $217M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $2.5B | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $677M | $458M | $1.1B | $706M | $1.2B | $1.1B | $850M | $254M | $337M | $621M |
| Dividends paid | $541M | $563M | $694M | $734M | $846M | $1.7B | $1.1B | $1.1B | $1.1B | $1.1B |
| Dividends and buybacks | $1.2B | $1.0B | $1.8B | $1.4B | $2.0B | $2.8B | $2.0B | $1.4B | $1.5B | $1.8B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $1.2B | $1.9B | $1.4B | $1.8B | $2.2B | $1.5B | $1.8B | $2.1B | $2.6B | $3.4B |
| Total debt | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $615M | $652M | $661M | $674M | $695M | $736M | $756M | $807M | $977M | $845M |
| Total assets | $6.2B | $7.5B | $7.7B | $9.3B | $10.7B | $12.5B | $11.6B | $12.3B | $13.5B | $14.3B |
| Total liabilities | $529M | $718M | $825M | $1.1B | $1.4B | $2.3B | $2.0B | $2.0B | $2.0B | $2.3B |
| Shareholders' equity | $5.0B | $5.8B | $6.1B | $7.1B | $7.7B | $9.0B | $8.8B | $9.5B | $10.3B | $10.9B |
| Margins | ||||||||||
| Operating margin | 40.5% | 43.4% | 44.0% | 42.5% | 44.2% | 48.4% | 36.6% | 30.7% | 32.9% | 29.9% |
| EBITDA margin | 43.6% | 46.4% | 46.9% | β | β | β | β | β | β | β |
| Net margin | 28.4% | 30.9% | 34.2% | 37.9% | 38.2% | 40.2% | 24.0% | 27.7% | 29.6% | 28.5% |
| FCF margin | 0.5% | 0.9% | 27.0% | 23.5% | 27.5% | 41.9% | 32.7% | 14.1% | 17.8% | 20.2% |
| Returns | ||||||||||
| Return on capital | 30.0% | 34.5% | 40.6% | 36.6% | 39.3% | 43.3% | 23.5% | 19.7% | 22.8% | 21.7% |
| Return on equity | 24.9% | 27.7% | 30.8% | 32.2% | 32.0% | 36.9% | 17.4% | 19.5% | 21.2% | 19.7% |
| Return on assets | 21.4% | 21.8% | 24.1% | 25.1% | 23.7% | 26.6% | 12.9% | 15.0% | 16.3% | 15.0% |
| Growth | ||||||||||
| Revenue growth | 2.0% | 13.3% | 10.7% | 4.6% | 10.5% | 23.6% | β15.4% | β0.4% | 9.8% | 3.1% |
| Net income growth | β0.7% | 23.3% | 22.7% | 16.0% | 11.3% | 29.9% | β49.5% | 14.8% | 17.4% | β0.6% |
| EPS growth | 2.6% | 25.7% | 21.8% | 19.7% | 14.7% | 31.5% | β48.9% | 15.8% | 17.9% | 1.0% |
| FCF growth | β98.4% | 95.5% | 3,244.2% | β9.2% | 29.3% | 88.5% | β34.0% | β57.1% | 38.5% | 17.2% |
| Share count change | β4.1% | β2.1% | 0.7% | β3.4% | β3.1% | β1.0% | β0.7% | β1.0% | β0.7% | β1.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | β0.7x | β0.8x | β0.6x | β | β | β | β | β | β | β |
| Debt / equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.5% | 3.8% | 3.1% | 3.6% | 3.5% | 3.1% | 3.7% | 4.8% | 6.0% | 3.8% |
| Stock comp / revenue | 3.8% | 3.1% | 3.7% | 3.7% | 4.0% | 3.6% | 4.4% | 4.1% | 3.5% | 3.0% |
| Payouts / FCF | 5,485.1% | 2,353.0% | 123.0% | 109.2% | 120.2% | 88.4% | 92.2% | 151.0% | 116.7% | 119.3% |
| Quality scores | ||||||||||
| Accruals ratio | 18.4% | 18.4% | 2.9% | 7.2% | 4.5% | β3.2% | β6.6% | 4.8% | 3.2% | 2.4% |
Source: SEC EDGAR XBRL filings (CIK 0001113169). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.